484 related articles for article (PubMed ID: 25277682)
21. Plasmatic oxidative stress biomarkers in multiple sclerosis: relation with clinical and demographic characteristics.
Pasquali L; Pecori C; Lucchesi C; LoGerfo A; Iudice A; Siciliano G; Bonuccelli U
Clin Biochem; 2015 Jan; 48(1-2):19-23. PubMed ID: 25300461
[TBL] [Abstract][Full Text] [Related]
22. Lipid peroxidation and antioxidant enzyme activities in erythrocytes of type 2 diabetic patients.
Likidlilid A; Patchanans N; Peerapatdit T; Sriratanasathavorn C
J Med Assoc Thai; 2010 Jun; 93(6):682-93. PubMed ID: 20572373
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of oxidative stress in autism: defective antioxidant enzymes and increased lipid peroxidation.
Meguid NA; Dardir AA; Abdel-Raouf ER; Hashish A
Biol Trace Elem Res; 2011 Oct; 143(1):58-65. PubMed ID: 20845086
[TBL] [Abstract][Full Text] [Related]
24. Impact of oral vitamin E supplementation on oxidative stress & lipid peroxidation in patients with polymorphous light eruption.
Ahmed RS; Suke SG; Seth V; Jain A; Bhattacharya SN; Banerjee BD
Indian J Med Res; 2006 Jun; 123(6):781-7. PubMed ID: 16885600
[TBL] [Abstract][Full Text] [Related]
25. Mitochondria-targeted Antioxidants as a Prospective Therapeutic Strategy for Multiple Sclerosis.
Fetisova E; Chernyak B; Korshunova G; Muntyan M; Skulachev V
Curr Med Chem; 2017; 24(19):2086-2114. PubMed ID: 28302008
[TBL] [Abstract][Full Text] [Related]
26. CSF inflammation and axonal damage are increased and correlate in progressive multiple sclerosis.
Romme Christensen J; Börnsen L; Khademi M; Olsson T; Jensen PE; Sørensen PS; Sellebjerg F
Mult Scler; 2013 Jun; 19(7):877-84. PubMed ID: 23178691
[TBL] [Abstract][Full Text] [Related]
27. [Investigation of oxidative stress and antioxidant defense in patients with hepatitis B virus infection and the effect of interferon-alpha plus lamivudine combination therapy on oxidative stress].
Acar A; Görenek L; Aydin A; Eyigün CP; Eken A; Sayal A; Pahsa A
Mikrobiyol Bul; 2009 Jul; 43(3):411-23. PubMed ID: 19795616
[TBL] [Abstract][Full Text] [Related]
28. Increased cerebrospinal fluid and plasma levels of ultraweak chemiluminescence are associated with changes in the thiol pool and lipid-soluble fluorescence in multiple sclerosis: the pathogenic role of oxidative stress.
Calabrese V; Bella R; Testa D; Spadaro F; Scrofani A; Rizza V; Pennisi G
Drugs Exp Clin Res; 1998; 24(3):125-31. PubMed ID: 9825228
[TBL] [Abstract][Full Text] [Related]
29. Plasma lipid peroxidation and progression of disability in multiple sclerosis.
Koch M; Mostert J; Arutjunyan AV; Stepanov M; Teelken A; Heersema D; De Keyser J
Eur J Neurol; 2007 May; 14(5):529-33. PubMed ID: 17437612
[TBL] [Abstract][Full Text] [Related]
30. Exercise-induced systemic effects in muscle-wasted patients with COPD.
Van Helvoort HA; Heijdra YF; Thijs HM; Viña J; Wanten GJ; Dekhuijzen PN
Med Sci Sports Exerc; 2006 Sep; 38(9):1543-52. PubMed ID: 16960513
[TBL] [Abstract][Full Text] [Related]
31. Demyelination, inflammation, and neurodegeneration in multiple sclerosis deep gray matter.
Vercellino M; Masera S; Lorenzatti M; Condello C; Merola A; Mattioda A; Tribolo A; Capello E; Mancardi GL; Mutani R; Giordana MT; Cavalla P
J Neuropathol Exp Neurol; 2009 May; 68(5):489-502. PubMed ID: 19525897
[TBL] [Abstract][Full Text] [Related]
32. Glutathione PEGylated liposomal methylprednisolone (2B3-201) attenuates CNS inflammation and degeneration in murine myelin oligodendrocyte glycoprotein induced experimental autoimmune encephalomyelitis.
Lee DH; Rötger C; Appeldoorn CC; Reijerkerk A; Gladdines W; Gaillard PJ; Linker RA
J Neuroimmunol; 2014 Sep; 274(1-2):96-101. PubMed ID: 25037177
[TBL] [Abstract][Full Text] [Related]
33. Iron supplementation at high altitudes induces inflammation and oxidative injury to lung tissues in rats.
Salama SA; Omar HA; Maghrabi IA; AlSaeed MS; EL-Tarras AE
Toxicol Appl Pharmacol; 2014 Jan; 274(1):1-6. PubMed ID: 24215938
[TBL] [Abstract][Full Text] [Related]
34. Peripheral oxidative stress in relapsing-remitting multiple sclerosis.
Tasset I; Agüera E; Sánchez-López F; Feijóo M; Giraldo AI; Cruz AH; Gascón F; Túnez I
Clin Biochem; 2012 Apr; 45(6):440-4. PubMed ID: 22330938
[TBL] [Abstract][Full Text] [Related]
35. Studies on lipid peroxidation and non-enzymatic antioxidant status as indices of oxidative stress in patients with chronic myeloid leukaemia.
Ahmad R; Tripathi AK; Tripathi P; Singh R; Singh S; Singh RK
Singapore Med J; 2010 Feb; 51(2):110-5. PubMed ID: 20358148
[TBL] [Abstract][Full Text] [Related]
36. Oxidative stress in ischaemic stroke.
Nanetti L; Raffaelli F; Vignini A; Perozzi C; Silvestrini M; Bartolini M; Provinciali L; Mazzanti L
Eur J Clin Invest; 2011 Dec; 41(12):1318-22. PubMed ID: 21623777
[TBL] [Abstract][Full Text] [Related]
37. Status of free radicals and antioxidants in leprosy patients.
Prabhakar MC; Santhikrupa D; Manasa N; Rao OU
Indian J Lepr; 2013; 85(1):5-9. PubMed ID: 24046909
[TBL] [Abstract][Full Text] [Related]
38. Effect of corticosteroid therapy on serum and CSF malondialdehyde and antioxidant proteins in multiple sclerosis.
Keles MS; Taysi S; Sen N; Aksoy H; Akçay F
Can J Neurol Sci; 2001 May; 28(2):141-3. PubMed ID: 11383939
[TBL] [Abstract][Full Text] [Related]
39. Tumor necrosis factor-alpha and its soluble receptors in plasma and cerebrospinal fluid of multiple sclerosis patients treated with methylprednisolone.
Franciotta D; Bergamaschi R; Martino G; Zardini E; Desina G; Cosi V
Eur Cytokine Netw; 1999 Sep; 10(3):431-6. PubMed ID: 10477400
[TBL] [Abstract][Full Text] [Related]
40. Free radicals, antioxidant defense systems, and schizophrenia.
Wu JQ; Kosten TR; Zhang XY
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():200-6. PubMed ID: 23470289
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
